While treatment of glioblastoma includes radiotherapy and chemotherapy, generally, glioblastomas (GBMs) are resistant to the current therapeutics due to the hyperactivation of the PI3K-Akt-mTOR survival pathway by excessive stimulation via growth factor receptors and Ras [60]. The gene discussed is MTOR; the disease is glioblastoma.